Skip to main content

Advertisement

Correction to: Frequent genetic aberrations in the cell cycle related genes in mucosal melanoma indicate the potential for targeted therapy

Article metrics

  • 66 Accesses

The original article was published in Journal of Translational Medicine 2019 17:245

Correction to: J Transl Med (2019) 17:245 https://doi.org/10.1186/s12967-019-1987-z

Following publication of the original article [1], the authors reported errors in Figures 2, 3 and Figure 3 ‘continued’.

  1. 1.

    In Figure 2b and 2f of PDX2 model, duplicated pictures of tumors have been used.

  2. 2.

    In Figure 3 of H&E staining of PDX-004, duplicated pictures have been used. Moreover, the description of the second PDX-001 was not correct in Figure 3.

  3. 3.

    In Figure 3 ‘continued’ of H&E staining, duplicated pictures have been used in all PDX groups. Moreover, the part labels in Figure 3 ‘continued’ were not correct.

In this Correction the corrected version of Figs. 2, 3 and Fig. 3 ‘continued’ are shown.

Fig. 2
figure2

Sensitivity of PDX models containing CDK4 aberrations to CDK4/6 inhibitors in vivo. When the tumor size reached approximately 600 mm3, mice (n = 4 per group) were treated with buffer control or inhibitors daily. Tumor volume was evaluated as % of the tumor volume on day 0 and presented as mean ± SD. The comparison of the growth curves was done with the repeated measure variance analysis. ns no significances; **P < 0.01; ***P < 0.001

Fig. 3
figure3figure3

Proliferation index of mucosal melanoma cells from PDX models containing CDK4 aberrations after CDK4/6 inhibitors treatments. On day 14 of treatments, the tumor nodules were excised and examined by H&E staining and immunohistochemical staining (for Ki-67). The sections were evaluated under microscope, and typical staining was photographed (a). The Ki-67 + cells under 5 random fields were counted. Bar = 20 μm. The results of Ki-67 + cells (bf) were presented as mean ± SD of three sections. ns no significances; *P < 0.05; **P < 0.01; ***P < 0.001

Reference

  1. 1.

    Xu L, Cheng Z, Cui C, Wu X, Yu H, Guo J, Kong Y. Frequent genetic aberrations in the cell cycle related genes in mucosal melanoma indicate the potential for targeted therapy. J Transl Med. 2019;17:245. https://doi.org/10.1186/s12967-019-1987-z.

Download references

Author information

Correspondence to Jun Guo or Yan Kong.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Xu, L., Cheng, Z., Cui, C. et al. Correction to: Frequent genetic aberrations in the cell cycle related genes in mucosal melanoma indicate the potential for targeted therapy. J Transl Med 17, 358 (2019) doi:10.1186/s12967-019-2106-x

Download citation